Pharma Marketing Network
MAY 9, 2025
What does it take to bring a life-saving therapy to market and ensure patients can actually access it? Behind every successful drug launch lies a labyrinth of negotiations, pricing models, and payer strategies. Understanding the pharmaceutical market access process is crucialnot only for commercialization teams but for marketers and strategists looking to position their brands competitively.
BioPharma Dive
MAY 9, 2025
Some providers may need to reduce services, lay off staff or close their doors if Congress enacts major cuts to the safety-net insurance program, experts say.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
MAY 9, 2025
The COVID-19 pandemic brought microbiology to the public eye, making terms like RT-PCR, antigen, and PPE kit part of everyday discussions. In the pharmaceutical world, another set of terms-coliforms and E. coli-carry immense importance, especially where water quality is concerned. Water is a critical utility in pharma manufacturing processes and is used in various stages, including formulation, cleaning, and even as raw material in some products.
STAT
MAY 9, 2025
WASHINGTON — U.S. regulators have approved the first cervical cancer testing kit that allows women to collect their own sample at home before shipping it to a laboratory, according to a medical device company. Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to collect vaginal samples that can detect the HPV virus that causes cervical cancer.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
The Guardian - Pharmaceutical Industry
MAY 9, 2025
Providing semaglutide for all those eligible may bring productivity gains as people are able to work more Giving weight loss jabs to everyone eligible for them could boost the UK economy by 4.5bn, according to research. Worldwide, about 3.8 billion people over 25 and just under 750 million children and young people are forecast to be overweight or obese by 2050.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaTech
MAY 9, 2025
Poor API quality may often lead to delays in production and a shortage of supply.
STAT
MAY 9, 2025
Less than two years ago, I completed a three-year emergency medicine residency and, after passing written and oral board exams, became a board-certified emergency physician. Now, the Accreditation Council for Graduate Medical Education is claiming that three years of personal and financial sacrifice are not enough. The ACGME reviews each specialty’s program requirements every 10 years, and it recently released their proposed updates for emergency medicine.
The Pharmacist
MAY 9, 2025
The provision of weight-loss medication in NHS primary care will be delivered through general practice in the first instance, but there is an ambition to explore other routes of delivery, Englands chief pharmaceutical officer (CPhO) has said. His comments follow media reports last week that suggested the government might pilot NHS delivery of weight-loss drugs […] The post CPhO: Ambition to explore weight-loss meds through non-GP routes appeared first on The Pharmacist.
STAT
MAY 9, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. I had planned to make this box about a recent study that confirmed some birds form friendships. But as a lapsed Catholic who spends too much of her time watching college basketball (shout-out Xavier University), I am *thrilled* that we’re getting a pope who seemingly knows ball.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
MAY 9, 2025
GSK reveals the data behind its linerixibat for itching associated with autoimmune liver disease PBC as it anticipates first approvals for the drug.
STAT
MAY 9, 2025
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
World Pharma News
MAY 9, 2025
An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPAR, which is central to the regulation of metabolic processes, can also influence the growth of prostate cancer cells. PPAR is already known to be a target of certain drugs used to treat type 2 diabetes.
STAT
MAY 9, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk about the FDA’s new artificial intelligence effort in the wake of mass layoffs, see AI darling Insitro cut staff, and more.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
MAY 9, 2025
Indias contract research, development and manufacturing organisation (CRDMO) sector, which serves global pharmaceutical companies, could see its revenue grow 13-15 per cent this fiscal after an estimated ~11 per cent growth in fiscal 2025 as supply chains worldwide diversify amid geopolitical uncertainties. The CRDMO sector, which researches the chemistry of, and develops and manufactures, small molecules (1), is expected to sustain higher operating margins of 26-28 per cent.
pharmaphorum
MAY 9, 2025
Hopes that the UK-US trade agreement would give some clarity on the situation for pharmaceuticals proved optimistic.
Pharmaceutical Commerce
MAY 9, 2025
Ways to reimagine pharmas operating model and KPIs for commercial success in an AI-driven future.
pharmaphorum
MAY 9, 2025
Cost-related nonadherence (CRN) the act of skipping doses, splitting pills, or delaying refills to save money is a major issue among US adults with chronic conditions.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmafile
MAY 9, 2025
Clinical biotech, Galimedix Therapeutics, has announced the completion of a single ascending dose (SAD) part of a phase 1 study of GAL-101, a novel therapy aimed to treat serious neurodegenerative eye and brain conditions. The SAD study showed that GAL-101 was well-tolerated and has a strong safety and pharmacokinetic profile. These promising results have allowed […] The post Galimedix completes key stage of clinical trial for treatment targeting eye and brain diseases appeared first on Ph
pharmaphorum
MAY 9, 2025
Biotech pressures exposed as big job losses are announced at Vor Bio, IGM Biosciences, Rallybio, Insitro, and Korro Bio.
Pharmafile
MAY 9, 2025
Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to accelerate its international growth and service expansion. Founded in London in 2018, PIO was the first SEO agency to serve highly regulated pharma and biotech markets. The company helps clients leverage upcoming technologies, especially artificial […] The post Apiary invests in life sciences SEO pioneer PIO to support global expansion appeared first
pharmaphorum
MAY 9, 2025
AstraZeneca's run of positive trial results with its cancer therapies has continued with a win for its immunotherapy Imfinzi in early bladder cancer
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmacy Times
MAY 9, 2025
The new at-home test aims to increase comfort and screening timeliness through a more accessible method.
Pharma Marketing Network
MAY 9, 2025
Is your healthcare advertising generating the conversions your pharma brand needs? In todays competitive, digitally saturated market, traditional messaging no longer cuts it. Precision targeting, performance insights, and adaptive content are essential to reach both healthcare professionals (HCPs) and patients effectively. Fortunately, the rise of data-driven strategies is helping marketers build more intelligent campaigns that truly convert.
Big Molecule Watch
MAY 9, 2025
Last week, Biocon Biologics Ltd (BBL) announced that the EMAs Committee for Medicinal Products for Human Use (CHMP) had issued positive opinions for Biocons two denosumab biosimilar candidates. The two candidates, VEVZUO and Denosumab BBL (the brand name is currently under approval), are each intended for distinct therapeutic indications. According to Biocon , VEVZUO is intended for the prevention of bone complications in adults with advanced cancer involving bone and the treatment of adults and
Pharmaceutical Commerce
MAY 9, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmExec
MAY 9, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharma and Life Sciences Blog
MAY 9, 2025
101 AI Use Cases That Are Redefining Procurement priyanka.katke Fri, 05/09/2025 - 22:57 Youve automated POs. Deployed chatbots. Built smarter dashboards. Yet, most procurement teams are still just scratching the surface of what artificial intelligence can do. This white paper goes further with 101 real-world AI use cases across the source-to-pay process.
pharmaphorum
MAY 9, 2025
With the FDA and EMA releasing their annual reports detailing novel drug approvals in 2024, a new pharmaphorum podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face in the year ahead.
Expert insights. Personalized for you.
52 
Let's personalize your content